What are Eli Lilly's GLP-1 drugs?

Eli Lilly's key GLP-1 drug is tirzepatide, sold as Mounjaro for diabetes and Zepbound for obesity.

Amylin is a hormone co-secreted with insulin that helps regulate appetite and blood sugar; Eli Lilly is developing drugs targeting it.

How did the positive data impact LLY stock?

The report did not mention an immediate impact, but suggests positive momentum that could support the stock long-term.

UBS: Eli Lilly May See More GLP-1 Pipeline Momentum

A UBS analyst believes Eli Lilly (LLY) could see additional momentum in its GLP-1 pipeline, driven by positive data on amylin and tirzepatide. The report highlights the data's potential to strengthen Lilly's position in the diabetes and obesity market.

July 16, 2026

2 min read

Source: MT Newswires

A UBS analyst sees potential for Eli Lilly (LLY) to gain further momentum in its GLP-1 pipeline, citing positive data on amylin and tirzepatide. The report, covered by MT Newswires, suggests the data supports the company's growth outlook.

Recommendation Change

The report did not mention any change in rating or price target, focusing instead on the positive momentum.

Analyst's Rationale

The analyst believes positive data on amylin and tirzepatide strengthens Eli Lilly's position in the GLP-1 market, potentially driving further momentum. Tirzepatide is the active ingredient in Mounjaro (for diabetes) and Zepbound (for obesity), while amylin is a hormone that regulates appetite.

Context

The comments come amid strong competition from Novo Nordisk (NVO) in the GLP-1 space. LLY shares have risen about 40% over the past year, supported by robust demand for diabetes and obesity drugs.

What to Make of It

While the analyst expresses optimism, investors should consider competitive and regulatory risks. Positive data boosts confidence in the company's pipeline, but competition may limit growth.

Frequently Asked Questions

GLP-1 drugs are a class of medications used for type 2 diabetes and obesity, mimicking a natural hormone that regulates blood sugar and appetite.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.